All stocks Β· ERIS
EL

Eris Lifesciences Limited

ERIS BSE Healthcare

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in va…

ISIN INE406M01024
Listed β€”
Quarters tracked 13
Filings 14 docs

About

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antiΒ–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Key Metrics

as of Sep 2026
Market Cap18,317 Cr
P/E27.90
Div Yield0.55 %
Book Valueβ‚Ή282.00
52w Highβ‚Ή1,745.00
52w Lowβ‚Ή1,200.00
Face Valueβ‚Ή1.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 444.00 277.00 315.00 650.00 579.00 405.00 400.00 437.00 457.00 341.00 324.00 410.00 411.00
Expenses 324.00 256.00 238.00 354.00 362.00 284.00 300.00 294.00 333.00 262.00 250.00 265.00 256.00
Operating Profit 120.00 22.00 77.00 297.00 216.00 121.00 100.00 143.00 123.00 79.00 74.00 144.00 156.00
OPM % 27.00 8.00 25.00 46.00 37.00 30.00 25.00 33.00 27.00 23.00 23.00 35.00 38.00
Other Income 26.00 27.00 10.00 24.00 23.00 17.00 8.00 6.00 5.00 20.00 3.00 7.00 4.00
Depreciation 40.00 39.00 39.00 39.00 38.00 43.00 47.00 46.00 46.00 29.00 28.00 25.00 20.00
Interest 42.00 43.00 45.00 46.00 45.00 53.00 55.00 56.00 56.00 29.00 15.00 7.00 7.00
Profit before tax 64.00 -33.00 4.00 235.00 156.00 41.00 6.00 46.00 27.00 42.00 35.00 120.00 133.00
Tax % 25.00 -74.00 21.00 36.00 36.00 26.00 70.00 39.00 36.00 5.00 9.00 2.00 16.00
Net Profit 48.00 -9.00 3.00 150.00 100.00 30.00 2.00 28.00 17.00 40.00 32.00 118.00 111.00
EPS in Rs 3.49 -0.62 0.23 10.98 7.34 2.24 0.13 2.06 1.25 2.90 2.33 8.66 8.14

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 1,822.001,698.001,487.001,331.001,216.001,109.001,020.00897.00761.00713.00605.00548.00
Expenses 1,209.001,210.001,031.00825.00727.00691.00661.00562.00445.00442.00435.00437.00
Operating Profit 612.00487.00456.00506.00488.00417.00359.00334.00316.00271.00171.00111.00
OPM % 34.0029.0031.0038.0040.0038.0035.0037.0042.0038.0028.0020.00
Other Income 84.0035.0033.0016.0025.0010.0011.0032.0028.0025.003.007.00
Interest 180.00220.0057.0021.003.001.002.0023.0010.001.000.000.00
Depreciation 154.00182.00102.0065.0051.0038.0045.0032.0022.0021.0020.0015.00
Profit before tax 362.00120.00329.00437.00459.00389.00324.00312.00312.00274.00154.00103.00
Tax % 33.0036.009.009.009.0010.0010.008.006.009.0010.0019.00
Net Profit 244.0077.00300.00398.00417.00351.00291.00285.00294.00248.00138.0083.00
EPS in Rs 17.625.6822.0329.2730.6925.8221.4520.7521.3618.0510,034.186,060.36
Dividend Payout % 41.00129.000.0025.0020.0021.0013.000.000.000.0061.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 14.0014.0014.0014.0014.0014.0014.0014.0014.0014.000.140.14
Reserves 3,182.002,501.002,510.002,208.001,905.001,562.001,286.001,142.00854.00561.00305.00267.00
Borrowings 2,101.002,245.002,572.00317.000.000.000.00176.00376.000.000.001.00
Other Liabilities 481.00463.00254.00245.00232.00179.00183.00138.00126.0082.0096.0086.00
Total Liabilities 5,778.005,222.005,350.002,784.002,150.001,755.001,483.001,470.001,370.00657.00402.00354.00
Fixed Assets 2,353.002,412.001,516.00898.00642.00584.00601.00484.00490.0092.0065.0061.00
CWIP 0.000.001.000.003.002.004.003.000.000.000.000.00
Investments 1,414.00991.001,619.00997.00778.00531.00320.00580.00546.00381.00206.00182.00
Other Assets 2,011.001,819.002,214.00889.00728.00638.00558.00403.00335.00184.00131.00110.00
Total Assets 5,778.005,222.005,350.002,784.002,150.001,755.001,483.001,470.001,370.00657.00402.00354.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 564.00702.00336.00322.00369.00395.00265.00216.00236.00210.00133.0092.00
Cash from Investing Activity -694.00-359.00-2,492.00-513.00-268.00-348.00127.002.00-593.00-199.00-45.00-94.00
Cash from Financing Activity 71.00-310.002,160.00194.00-88.00-81.00-334.00-221.00363.00-18.00-84.001.00
Net Cash Flow -59.0032.004.003.0013.00-34.0058.00-2.007.00-6.004.00-1.00
Free Cash Flow 515.00694.00-13.0011.00317.00370.00121.00180.00212.00161.00109.0079.00
CFO/OP % 104.00147.0090.0079.0093.00111.0088.0086.0096.0097.0096.00104.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 62.0051.0059.0063.0041.0037.0050.0031.0029.0021.0015.0016.00
Inventory Days 71.00140.00119.0098.00155.00119.00145.00206.00194.00161.00156.00181.00
Days Payable 128.00158.00143.00128.00177.00159.00200.00207.00266.0086.0088.00121.00
Cash Conversion Cycle 4.0033.0035.0033.0019.00-3.00-4.0030.00-43.0097.0084.0075.00
Working Capital Days -145.00-99.00-413.0052.0080.0065.0058.00-22.002.0031.008.0013.00
ROCE % 11.007.0010.0020.0027.0027.0024.0026.0035.0062.0053.0044.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 54.14 53.92 54.85 54.85 54.83 54.85 54.86 54.87 54.88 54.90 54.90 54.91
FIIs 5.76 6.39 6.85 7.21 8.39 8.43 8.36 8.01 14.59 14.27 13.13 13.20
DIIs 20.71 20.35 20.31 19.36 18.18 18.07 18.07 18.64 16.23 15.63 14.55 14.52
Public 19.39 19.33 17.97 18.57 18.59 18.64 18.73 18.47 14.30 15.20 17.41 17.37
No. of Shareholders 50,798 51,656 54,713 59,438 52,225 50,087 53,314 46,346 44,176 51,753 46,496 42,245

Corporate Actions

16 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 29 May 2026 29 May 2026 β€” 7.21
Dividend 13 Feb 2025 13 Feb 2025 β€” 7.35
Other 17 Sep 2024 β€” β€” β€” Annual General Meeting
Other 15 Sep 2023 β€” β€” β€” Annual General Meeting
Other 23 Aug 2022 β€” β€” β€” Annual General Meeting
Dividend 11 Aug 2022 16 Aug 2022 β€” 7.35
Other 23 Aug 2021 β€” β€” β€” Annual General Meeting
Dividend 05 Aug 2021 06 Aug 2021 β€” 6.01
Other 18 Sep 2020 β€” β€” β€” Annual General Meeting
Dividend 13 Aug 2020 14 Aug 2020 β€” 5.50
Dividend 19 Mar 2020 20 Mar 2020 β€” 2.87
Other 18 Sep 2019 β€” β€” β€” Annual General Meeting
Other 12 Jul 2019 15 Jul 2019 β€” β€” Buy Back of Shares
Other 12 Jul 2019 15 Jul 2019 β€” β€” Buyback
Other 19 Sep 2018 β€” β€” β€” Annual General Meeting
Other 20 Sep 2017 β€” β€” β€” Annual General Meeting

Announcements

5 filings